Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study-Reference-Cited by-同舟云学术

Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study

Published:2017-01 Issue:1 Volume:18 Page:52-62
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Luen Stephen J,Salgado Roberto,Fox Stephen,Savas Peter,Eng-Wong Jennifer,Clark Emma,Kiermaier Astrid,Swain Sandra M,Baselga Jose,Michiels Stefan,Loi Sherene

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer;Swain;N Engl J Med,2015

3. Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer;Baselga;J Clin Oncol,2014

4. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth;Agus;Cancer Cell,2002

5. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex;Franklin;Cancer Cell,2004

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance;Nature Reviews Clinical Oncology;2024-09-13

2. Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study;Future Oncology;2024-08-12

3. The conflicting prognostic role of the stroma-ratio in breast cancer molecular subtypes;Modern Pathology;2024-08

4. To develop a prognostic model for neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma by analyzing the immune microenvironment;Frontiers in Immunology;2024-04-25

5. Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes;Biomedicines;2024-03-29